apollo
0
Written By Bayyarapu Mahesh Kumar , M Pharmacy
Last Updated Jan 1, 2025 | 9:32 AM IST

Femmeola 150 mg Tablet 60's is used to treat various cancers, including ovarian, breast, pancreatic, and prostate. It contains Olaparib, a targeted drug called a PARP inhibitor. PARP is a protein that helps damaged cells repair themselves. Olaparib stops PARP working. Some cancer cells rely on PARP to keep their DNA healthy. So, the cancer cells die when Olaparib stops PARP from repairing DNA damage. Avoid taking this medication if you are pregnant or breastfeeding because this can cause harmful effects on the unborn baby. Both women and men using this should use birth control to avoid pregnancy.

Read more
Prescription drug
 Trailing icon
Prescription drug

Whats That

tooltip
Consult Doctor

Composition :

OLAPARIB-150MG

Manufacturer/Marketer :

MEDICAMEN BIOTECH LTD

Consume Type :

ORAL

Return Policy :

Not Returnable

About Femmeola 150 mg Tablet 60's

Femmeola 150 mg Tablet 60's is an 'anti-cancer' drug used to treat various cancers, including ovarian, breast, pancreatic, and prostate. Cancer is a condition where cells in a specific body part grow and reproduce uncontrollably. The cancerous cells can attack and destroy surrounding healthy tissue, including organs.

Femmeola 150 mg Tablet 60's contains Olaparib, a targeted drug called a PARP inhibitor. PARP (polyadenosine 5’-diphosphoribose polymerase) is a protein that helps damaged cells repair themselves. Olaparib stops PARP working. Some cancer cells rely on PARP to keep their DNA healthy. So, the cancer cells die when Olaparib stops PARP from repairing DNA damage.

Use this medicine as directed by your doctor. You may sometimes experience shortness of breath (dyspnoea), feeling very tired, pale skin or fast heartbeat, anaemia, feeling sick (nausea), being sick (vomiting), indigestion or heartburn (dyspepsia), loss of appetite, headache, changes in taste of foods (dysgeusia), feeling dizzy, cough and diarrhoea. Most of these side effects may gradually resolve over time. However, if the side effects persist or worsen, consult your doctor.

To treat your condition effectually, continue taking Femmeola 150 mg Tablet 60's for as long as your doctor has prescribed. Do not stop using the Femmeola 150 mg Tablet 60's midway. Talk to your doctor before taking Femmeola 150 mg Tablet 60's if you have severe allergic reactions to Femmeola 150 mg Tablet 60's or other medicines or suffer from severe infections, renal dysfunction, hepatic disorders and blood cell counts are too low. Avoid taking Femmeola 150 mg Tablet 60's if you are pregnant or breastfeeding because this Femmeola 150 mg Tablet 60's can cause harmful effects on the unborn baby. Both women and men using this Femmeola 150 mg Tablet 60's should use birth control to avoid pregnancy. While on Femmeola 150 mg Tablet 60's treatment, you should avoid eating grapefruit, Seville oranges or consuming grapefruit juice since it can affect how the medicine works.

Uses of Femmeola 150 mg Tablet 60's

Treatment of Ovarian cancer, breast cancer, pancreatic cancer, and prostate cancer

Medicinal Benefits

Femmeola 150 mg Tablet 60's belongs to a group of medicines known as 'anti-cancer' drugs used to treat various cancers, including Ovarian, breast, pancreatic, and prostate.  Femmeola 150 mg Tablet 60's contains Olaparib, a targeted drug called a PARP inhibitor. PARP (polyadenosine 5’-diphosphoribose polymerase) is a protein that helps damaged cells repair themselves. Olaparib stops PARP working. Some cancer cells rely on PARP to keep their DNA healthy. So, the cancer cells die when Olaparib stops PARP from repairing DNA damage.

Side Effects of Femmeola 150 mg Tablet 60's

  • Feeling sick (nausea)
  • Being sick (vomiting)
  • Feeling tired or weak (fatigue)
  • Feeling very tired
  • Indigestion or heartburn (dyspepsia)
  • Loss of appetite
  • Headache
  • Changes in the taste of foods (dysgeusia)
  • Feeling dizzy
  • Cough
  • Shortness of breath (dyspnoea)
  • Diarrhoea
  • Low white blood cell count (leukopenia or neutropenia)
  • Rash
  • Sore mouth (stomatitis)
  • Upper abdominal pain (pain in the stomach area under the ribs)
  • Blood clot in a deep vein, usually in the leg (venous thrombosis)

Directions for Use

Swallow it as a whole with water; do not crush or chew it.

Storage

Store in a cool and dry place away from sunlight

Drug Warnings

Always take this medicine exactly as your doctor or healthcare professional has told you. To treat your condition effectually, continue taking Femmeola 150 mg Tablet 60's for as long as your doctor has prescribed. Do not stop Femmeola 150 mg Tablet 60's midway. Talk to your doctor before taking Femmeola 150 mg Tablet 60's if you have severe allergic reactions to Femmeola 150 mg Tablet 60's or other medicines or suffer from any medical illness. Avoid taking Femmeola 150 mg Tablet 60's if you are pregnant or breastfeeding because this Femmeola 150 mg Tablet 60's can cause harmful effects on the unborn baby. Both women and men using this Femmeola 150 mg Tablet 60's should use birth control to avoid pregnancy. Do not start Femmeola 150 mg Tablet 60's unless patients have recovered from haematological damage induced by previous chemotherapy (Grade 1). Check full blood count for cytopenia at baseline and monthly afterwards for clinically significant changes during treatment. For persistent haematological toxicity, discontinue Femmeola 150 mg Tablet 60's and monitor blood count weekly until recovery. Do not receive any immunization or vaccination without your doctor's approval while taking the Femmeola 150 mg Tablet 60's.

Therapeutic Class

ANTINEOPLASTIC

Drug-Drug Interactions

verifiedApollotooltip
OlaparibCeritinib
Severe
OlaparibLeflunomide
Severe

Drug-Food Interactions

verifiedApollotooltip
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.

Diet & Lifestyle Advise

  • De-stress yourself by meditating, reading books, taking a warm bubble bath or listening to soothing music.
  • Performing yoga may also help in improving both physical and mental health.
  • Maintain a healthy weight by performing regular low-strain exercises and eating healthy food.
  • Eat a healthy diet and exercise regularly to maintain proper weight.
  • Include leafy vegetables, citrus fruits, fatty fish, berries, yoghurt, apples, peaches, cauliflower, cabbage, broccoli, beans, and herbs.
  • Get optimal sleep; rest well.
  • Avoid smoking and alcohol consumption.
  • Avoid fast, fried, processed meats, refined carbs and added sugars.

Habit Forming

No

How Femmeola 150 mg Tablet 60's Works

Femmeola 150 mg Tablet 60's contains Olaparib, a targeted drug called a PARP inhibitor. PARP (polyadenosine 5’-diphosphoribose polymerase) is a protein that helps damaged cells repair themselves. Olaparib stops PARP working. Some cancer cells rely on PARP to keep their DNA healthy. So, the cancer cells die when Olaparib stops PARP from repairing DNA damage.

What if I have taken an overdose of Femmeola 150 mg Tablet 60's

Do not take more than the prescribed dose. Using more medication will not improve your symptoms; instead, they may cause serious side effects or poisoning. If you suspect that you may have overdosed of Femmeola 150 mg Tablet 60's or observe any side effects, please go to the emergency department of the closest hospital or nursing home. No specific side effects have been reported under these circumstances.
bannner image

Alcohol

Caution

Avoid alcohol consumption while on treatment with Femmeola 150 mg Tablet 60's.

bannner image

Pregnancy

Unsafe

Femmeola 150 mg Tablet 60's should not be used during pregnancy because it can harm your fetus (newborn baby). Both women of childbearing potential and men must use an effective contraception method while taking Femmeola 150 mg Tablet 60's and at least for six months later treatment. Your doctor will weigh the benefits and risks before prescribing this medicine.

bannner image

Breast Feeding

Unsafe

Do not breastfeed during this treatment because the medicine may pass into your milk. Doctors normally advise against breastfeeding throughout this treatment and for one month after the final medication is taken.

bannner image

Driving

Caution

Femmeola 150 mg Tablet 60's may affect your reactions and your ability to drive. Do not drive and/or operate machines that require your alertness.

bannner image

Liver

Caution

In patients with mild or moderate liver impairment, there is no need to alter the initial dose. There is no information available on patients with severe liver impairment.

bannner image

Kidney

Caution

In patients with mild or moderate kidney impairment, there is no need to alter the initial dose. There is no information available on patients with severe kidney impairment.

bannner image

Children

Caution

The safety and effectiveness of Femmeola 150 mg Tablet 60's in pediatric patients have not been established.

Country of origin

India

Manufacturer/Marketer address

Plot no 84 and 85 , sector 6A , IIE sidcul , bhel , ranipur , Haridwar 249403 ( uttarakhand ) India
Other Info - FEM0453

FAQs

Femmeola 150 mg Tablet 60's is used to treat ovarian, breast, pancreatic, and prostate cancers.
Femmeola 150 mg Tablet 60's contains Olaparib, a targeted drug called a PARP inhibitor. PARP is a protein that helps damaged cells to repair themselves. Olaparib stops PARP working. Some cancer cells rely on PARP to keep their DNA healthy. So, the cancer cells die when Olaparib stops PARP from repairing DNA damage.
If you are allergic to Olaparib or any other ingredients in this medication, are breastfeeding, or have too low blood cell counts, you should not use Femmeola 150 mg Tablet 60's.
Yes, Femmeola 150 mg Tablet 60's can cause low neutrophils levels, a type of white blood cells that help fight infections. If your white blood cells become low, you can be at higher risk for infections. Tell your doctor if you develop a fever or have an infection.
Do not have immunizations/vaccinations without talking to your doctor first. Also, avoid contact with people who recently had immunizations /vaccinations.

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.